^
    6ms
    Dose Finding Study of GH35 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=18, Active, not recruiting, Suzhou Genhouse Bio Co., Ltd. | Recruiting --> Active, not recruiting | N=38 --> 18
    Enrollment closed • Enrollment change
    |
    KRAS (KRAS proto-oncogene GTPase)
    |
    GH35